furosemide
- Product NDC
- 69844-053
- 11-digit product format
- 698440053
- Labeler code
- 69844
- Product ID
- 69844-053_415be125-eca2-43d6-b544-947647377f3b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- furosemide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Graviti Pharmaceuticals Private Limited
- Application
- ANDA216629
- Marketing category
- ANDA
- Marketing start
- 2022-10-17
- Marketing end
- 0000-00-00
- Substance
- FUROSEMIDE
- Active strength
- 80 mg/1
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69844-053-01 | 69844005301 | 50 TABLET in 1 BOTTLE (69844-053-01) | 50 tablet | 2022-10-17 | 0000-00-00 | No | No | Current |
| 69844-053-02 | 69844005302 | 100 TABLET in 1 BOTTLE (69844-053-02) | 100 tablet | 2022-10-17 | 0000-00-00 | No | No | Current |
| 69844-053-03 | 69844005303 | 1000 TABLET in 1 BOTTLE (69844-053-03) | 1000 tablet | 2022-10-17 | 0000-00-00 | No | No | Current |